ENFY
Enlightify Inc.0.0900
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
1.42MP/E (TTM)
-Basic EPS (TTM)
-0.86Dividend Yield
0%Recent Filings
10-Q
10-K
FY2025 results
Enlightify Inc. reported FY2025 revenues of $75.3M, down 21.5% y/y from $95.8M in FY2024, driven by a 30% drop in Gufeng's fertilizer sales to $36.5M amid market pressures, though Jinong's volumes rose 17.4% to 39,304 tons while prices fell 24.1%. Q4 showed sequential stabilization with Gufeng's sales rebounding modestly from Q3 lows, but overall quarterly momentum remained soft due to persistent demand weakness in China's fertilizer sector. Gross margins improved to 22.7% from 20.6%, thanks to cost controls, yet net loss narrowed to $15.6M from $28.4M, aided by 40% lower G&A expenses. Liquidity stood at $52.5M in cash with $12.6M debt, supporting no dividends or buybacks beyond 346K shares repurchased for $0.4M; no annual guidance issued. VIE structure risks could disrupt quarterly operations.
8-K
NYSE price deficiency notice
Enlightify Inc. received NYSE notice on August 27, 2025, after its 30-trading-day average closing price dipped below $1.00, breaching continued listing rules. The company responded on September 9, 2025, committing to cure the deficiency within six months to avoid delisting. Shares remain traded on NYSE without impacting operations or reporting duties. Compliance hinges on boosting the share price.
8-K
NYSE delisting warning issued
Enlightify Inc. received NYSE notice on August 27, 2025, for its common stock's 30-trading-day average closing price dipping below $1.00, breaching continued listing rules. The company plans to notify NYSE by September 11 of its intent to cure, targeting compliance by February 27, 2026, or earlier. Trading persists uninterrupted. This non-compliance poses delisting risk if unresolved.
10-Q
Q3 FY2025 results
Enlightify's Q3 FY2025 results show revenue dipping 24.8% y/y to $24.8M, driven by softer pricing at Jinong (down 11.8% y/y) and lower volumes at Gufeng (down 30.5% y/y), yet gross margins edged up to 20.0% from 19.3% on cost efficiencies. Operating loss narrowed sharply to $0.6M from $11.0M, thanks to G&A expenses plunging 75.1% y/y amid reduced bad debt provisions; diluted EPS improved to -$0.06 from -$0.79, aligning with 14.6M shares. Cash stood at $48.8M after $7.3M operating outflow, offset by $3.2M financing inflows including loan proceeds, while total debt rose to $12.6M at 3.55%-5.00% rates maturing through 2027. No material M&A closed, but a pending Texas lawsuit over crypto funds adds uncertainty. Gufeng remains the revenue powerhouse at 63%. Regulatory shifts in PRC fertilizer VAT could squeeze margins further.
AGRI
AgriFORCE Growing Systems Ltd.
2.33+0.29
CF
CF Industries Holdings, Inc.
77.55-1.20
CTVA
Corteva, Inc.
65.48-0.40
HYFM
Hydrofarm Holdings Group, Inc.
2.44+0.40
ICL
ICL Group Ltd.
4.93-0.05
LVRO
Lavoro Limited
0.64-0.02
MOS
Mosaic Company (The)
23.46-1.40
NTR
Nutrien Ltd.
61.85+0.00
SEED
Origin Agritech Limited
1.37+0.08
UAN
CVR Partners, LP
94.78-0.78